Market Place
Sourcing Support
XPhyto Reports Excellent Rotigotine In-Vitro/Ex-Vivo Results for Parkinson
18 Oct 2022 //
ACCESSWIRE
XPhyto Completes TDS Patch Optimization & Comparative Skin Absorption Study
11 Oct 2022 //
BIOSPACE
XPhyto Signs Letter of Intent for US Manufacturing and Strategic Business
04 Oct 2022 //
ACCESSWIRE
XPhyto Files Patent Application for Library of Novel Psychedelic Compounds
20 Sep 2022 //
ACCESSWIRE
XPhyto Closes Final Tranche of Fully Subscribed Financing
02 Sep 2022 //
ACCESSWIRE
XPhyto Closes Second Tranche of Financing
31 Aug 2022 //
ACCESSWIRE
XPhyto Reports Platform-Based Rotigotine Transdermal Patch for PD
09 May 2022 //
ACCESSWIRE
XPhyto, Biosensors Market & Product Developments on Oral Dissolvable Biosensors
11 Apr 2022 //
ACCESSWIRE
XPhyto Reports Product Developments on Rotigotine Transdermal Patch for PD
04 Apr 2022 //
ACCESSWIRE
XPhyto Closes First Tranche of Financing
31 Mar 2022 //
ACCESSWIRE
XPhyto Executes Covid-ID Lab Sales Contracts with Test Clinics and Pharmacies
01 Feb 2022 //
ACCESSWIRE
XPhyto Completes Strategic Acquisition of 3a-diagnostics GmbH
06 Dec 2021 //
BIOSPACE
XPhyto Reports Development Update for its Drug Delivery Business
12 Oct 2021 //
ACCESSWIRE
InvestorBrandNetwork (IBN) Announces Latest Episode of The Bell2Bell Podcast
17 Jun 2021 //
GLOBENEWSWIRE
XPhyto Featured in Syndicated Broadcast providing Update on Psychedelic Therapy
15 Jun 2021 //
GLOBENEWSWIRE
Copyright © 2024 LePro PharmaCompass OPC Private Limited, All rights reserved.